PULM logo Pulmatrix : PULM

PULM

Stock Data

$1.32

Change up

$0.03 (2.33%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company is headquartered in Lexington, Massachusetts.

All Pulmatrix Articles

1 Article

No articles found for Pulmatrix.